Come up with a name for your new list and we'll add to it:
CoLucid Pharmaceuticals raised a round of funding on March 01, 2017. Investors include
Eli Lilly & Co..
CoLucid Pharmaceuticals (NASDAQ: CLCD) aims to advance drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's pipeline includes lasmiditan, a trea…